"/>

    India's pharma sector pins hope after China exempts import tariffs for 28 drugs
    Source: Xinhua   2018-05-08 21:04:12

    By Pankaj Yadav

    NEW DELHI, May 8 (Xinhua) -- India is committed to promoting its pharmaceutical exports to untapped markets, including China, said Indian companies at a three-day international exhibition of pharma and healthcare (iPHEX) which kicked off on Tuesday.

    The exhibition has been organized by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) in which more than 650 delegates from 130 countries and regions are participating.

    China has exempted import tariffs for 28 drugs, including all cancer drugs, from May 1, which was seen as a good news for India's pharmaceutical industry and medicine export to China, as it would help in reducing trade imbalance between China and India in the future.

    Leading Indian companies participating in Tuesday's event hailed and welcomed China's move saying it would benefit both sides, as it would address India's trade imbalance and also China would get quality drugs at much lesser prices.

    Dr Dinesh Dua, the chief executive officer (CEO) of Nectar Lifesciences Ltd. based in Chandigarh city in northern India, said that he expected China, which is the second largest drugs market after the United States, would benefit a lot as Indian drugs prices are excellent.

    Indian companies can do excellent business in the next years in China, which augurs really well for the Indian pharmaceutical companies, he added.

    Besides cancer drugs, Due said, other drugs which India can export to China include "monoclonol antibodies" and also "chemotherapeutic agents" which Indian companies are very successfully making for other countries at a fraction of cost which innovators are making available.

    "The multinational companies (MNCs) are making available these generic drugs in China as local generic companies can't make them. India has proven to the rest of the world, so China will too greatly benefit by Indian pricing and quality of drugs coming in at a fraction of cost of the MNCs," Dua said.

    According to official figures, during the 11 months from April 2017 to January 2018, the pharma exports were recorded at 10.76 billion U.S. dollars in India. The exports are expected to grow by 30 percent over the next three years to reach 20 billion U.S.dollars by 2020.

    Indian pharmaceutical sector is estimated to account for 3.1-3.6 percent of the global pharmaceutical industry in value terms, and 10 percent in volume terms.

    India is believed to be the largest provider of generic drugs globally with the Indian generics accounting for 20 percent of global exports in terms of volume.

    In India cost of production of pharmaceutical items is nearly 33 percent lower than that of the United States, labor costs are 50-55 percent cheaper than in western countries. And, also the cost of setting up a production plant in India is 40 percent lower than in the West.

    Editor: ZX
    Related News
    Xinhuanet

    India's pharma sector pins hope after China exempts import tariffs for 28 drugs

    Source: Xinhua 2018-05-08 21:04:12
    [Editor: huaxia]

    By Pankaj Yadav

    NEW DELHI, May 8 (Xinhua) -- India is committed to promoting its pharmaceutical exports to untapped markets, including China, said Indian companies at a three-day international exhibition of pharma and healthcare (iPHEX) which kicked off on Tuesday.

    The exhibition has been organized by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) in which more than 650 delegates from 130 countries and regions are participating.

    China has exempted import tariffs for 28 drugs, including all cancer drugs, from May 1, which was seen as a good news for India's pharmaceutical industry and medicine export to China, as it would help in reducing trade imbalance between China and India in the future.

    Leading Indian companies participating in Tuesday's event hailed and welcomed China's move saying it would benefit both sides, as it would address India's trade imbalance and also China would get quality drugs at much lesser prices.

    Dr Dinesh Dua, the chief executive officer (CEO) of Nectar Lifesciences Ltd. based in Chandigarh city in northern India, said that he expected China, which is the second largest drugs market after the United States, would benefit a lot as Indian drugs prices are excellent.

    Indian companies can do excellent business in the next years in China, which augurs really well for the Indian pharmaceutical companies, he added.

    Besides cancer drugs, Due said, other drugs which India can export to China include "monoclonol antibodies" and also "chemotherapeutic agents" which Indian companies are very successfully making for other countries at a fraction of cost which innovators are making available.

    "The multinational companies (MNCs) are making available these generic drugs in China as local generic companies can't make them. India has proven to the rest of the world, so China will too greatly benefit by Indian pricing and quality of drugs coming in at a fraction of cost of the MNCs," Dua said.

    According to official figures, during the 11 months from April 2017 to January 2018, the pharma exports were recorded at 10.76 billion U.S. dollars in India. The exports are expected to grow by 30 percent over the next three years to reach 20 billion U.S.dollars by 2020.

    Indian pharmaceutical sector is estimated to account for 3.1-3.6 percent of the global pharmaceutical industry in value terms, and 10 percent in volume terms.

    India is believed to be the largest provider of generic drugs globally with the Indian generics accounting for 20 percent of global exports in terms of volume.

    In India cost of production of pharmaceutical items is nearly 33 percent lower than that of the United States, labor costs are 50-55 percent cheaper than in western countries. And, also the cost of setting up a production plant in India is 40 percent lower than in the West.

    [Editor: huaxia]
    010020070750000000000000011100001371645361
    主站蜘蛛池模板: 日本亚洲精品色婷婷在线影院| 厨房掀起馊子裙子挺进去视频 | 国产aaaaaa| 一本一本久久a久久综合精品蜜桃| 国产曰批免费视频播放免费s| 日本精a在线观看| 国产精品成人四虎免费视频| 亚州av综合色区无码一区| 试看91福利区体验区120秒| 成人18视频在线观看| 亚洲精品短视频| 亚洲va欧美va| 投资6000能开一个sf吗| 人人爽人人澡人人高潮| 97久视频精品视频在线老司机| 欧美亚洲国产精品久久高清| 国产在线一区二区三区在线| 一级女性全黄生活片免费看| 欧美激情第1页| 国产悠悠视频在线播放| 中文字幕乱理片免费完整的| 狠狠躁夜夜躁av网站中文字幕| 国产精品一区91| 丰满的己婚女人| 激性欧美激情在线播放16页| 国产成人综合久久久久久| 两个人看的www免费高清| 欧美日韩视频在线第一区| 动漫精品一区二区三区3d| **实干一级毛片aa免费| 日本免费高清一本视频| 亚洲国产精品嫩草影院| 荡乱妇3p疯狂伦交下载阅读| 天天做天天爱夜夜爽| 五月婷婷激情视频| 波多野结衣大战欧美黑人| 国产后入又长又硬| 1300部小u女视频大全合集| 奇米影视亚洲春色| 久久综合九色综合97免费下载| 精品国产乱码一区二区三区麻豆|